Milan, Lombardy, Italy Among the various public portfolio startups of the fund, we may underline Philogen Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biopharma, Biotechnology.
The typical case for the fund is to invest in rounds with 1 participant.
The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2019.
| Fund Name | Location |
| Africa Agriculture and Trade Investment Fund | - |
| Behrman Capital | New York, New York, United States |
| CEWE Photoworld | United Kingdom, Warwick, Warwickshire |
| Fengshui Capital Inc. | - |
| GRIL Ventures | Isle of Man, Middle, NA - Isle of Man |
| Henderson Global Investors | England, London, United Kingdom |
| LaunchByte | Boston, Massachusetts, United States |
| Marquette Venture Partners | Horseshoe Bay, Texas, United States |
| Must Asset Management | Seoul, Seoul-t'ukpyolsi, South Korea |
| NetMile | Japan, Tokyo |
| Pfannenberg Group | - |
| Red Light Management | Charlottesville, United States, Virginia |
| Shenzhenshi Yunhang Keji Youxian Gongsi | China, Guangdong, Shenzhen |
| Sihe Investment | Beijing, Beijing, China |
| Sunny Side Up | Japan, Tokyo |
| The Cleveland Foundation | Cleveland, Ohio, United States |
| The Seed Capital | Japan, Tokyo |
| Vontobel European Ventures. | - |
| Xiaofu Capital | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Engitix | $54M | 19 Jan 2022 | London, England, United Kingdom | ||
mPharma | $18M | 26 May 2020 | Accra, Ghana |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Engitix | $54M | 19 Jan 2022 | London, England, United Kingdom | ||
mPharma | $18M | 26 May 2020 | Accra, Ghana |
